Using Medicaid data (2017 to 2018) from four states participating in a distributed research network, this retrospective cohort study documents the prevalence of specific types of co-occurring substance use disorder (SUD) among Medicaid enrollees with an opioid use disorder (OUD) diagnosis.
Senior Policy Analyst Shamis Mohamoud and Policy Analyst Rosa Perez were part of the Medicaid Outcomes Distributed Research Network (MODRN) team of authors of this article published in the Journal of Substance Abuse Treatment.
Follow-up after residential treatment is considered best practice in supporting patients with opioid use disorder (OUD) in their recovery. Yet, little is known about rates of follow-up after discharge. The objective of this analysis was to measure rates of follow-up and use of medications for OUD (MOUD) after residential treatment among Medicaid enrollees in 10 states, and to understand the enrollee and episode characteristics that are associated with both outcomes.
Senior Policy Analyst Shamis Mohamoud was part of the Medicaid Outcomes Distributed Research Network (MODRN) team of authors of this article published in Drug and Alcohol Dependence.
In the US, Medicaid covers over 80 million Americans. Comparing access, quality, and costs across Medicaid programs can provide policymakers with much-needed information. As each Medicaid agency collects its member data, multiple barriers prevent sharing Medicaid data between states. To address this gap, the Medicaid Outcomes Distributed Research Network (MODRN) developed a research network of states to conduct rapid multi-state analyses without sharing individual-level data across states.
Senior Policy Analyst Shamis Mohamoud and Director of Medicaid Policy Studies David Idala were part of the Medicaid Outcomes Distributed Research Network (MODRN) team of authors of this article published in Medical Care.
This infographic describes the Hilltop Pre-AH Model, its development, and its use.
The Model Waiver provides services to individuals with medically complex needs and a chronic hospital or nursing facility level of care to be supported in their own homes or community-based settings. A unique aspect of the Model Waiver is that, due to the medically complex needs of its participants, non-waiver expenditures typically far exceed waiver expenditures. This infographic provides information for fiscal years (FYs) 2016 through 2020.
The Community Pathways Waiver provides community-based services and supports to individuals with developmental or intellectual disabilities. The waiver includes both self-directed and traditional service delivery models. This infographic presents information for fiscal years (FYs) 2016 through 2020.
The Brain Injury (BI) Waiver provides services to individuals aged 22 or older with a brain injury diagnosis who require specialty hospital or nursing facility level of care to be supported in their own homes or community-based settings. Each year, the Maryland Department of Health strives to serve an additional ten participants through the BI Waiver. This infographic presents information for fiscal years (FYs) 2016 through 2020.
Autism Waiver services enable individuals who have Autism Spectrum Disorder and who meet an institutional level of care to be supported in their own homes or community-based settings. This infographic provides information about Maryland Medicaid participants who received services through the Autism Waiver in fiscal years (FYs) 2016 through 2020.
This chart book, prepared for the Maryland Department of Health, compares the FY 2022 Medicaid reimbursement rates of Maryland and its surrounding states with Maryland’s Medicare fee schedule for CY 2021 for the Baltimore region. The surrounding states included in this study are Washington, DC; Delaware; Pennsylvania; Virginia; and West Virginia.
In 1997, Maryland implemented HealthChoice—a statewide mandatory Medicaid and Children’s Health Insurance Program (CHIP) managed care program—under authority of a waiver through §1115 of the Social Security Act. The provisions of the Affordable Care Act (ACA) that went into effect in 2014 marked another milestone by extending quality coverage to many more Marylanders with low income by calendar year (CY) 2018. Over 20 years after its launch, HealthChoice covered close to 90 percent of the state’s Medicaid and Maryland Children’s Health Program (MCHP) populations.
The Hilltop Institute, on behalf of the Maryland Department of Health (the Department), evaluates the program annually; this evaluation covers the period from CY 2016 through CY 2020.